erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Dysarthria D004401 2 associated lipids
Factor X Deficiency D005171 2 associated lipids
Elephantiasis D004604 2 associated lipids
Mastoiditis D008417 2 associated lipids
Pityriasis Lichenoides D017514 2 associated lipids
Postgastrectomy Syndromes D011178 2 associated lipids
Ehrlichiosis D016873 2 associated lipids
Herpes Genitalis D006558 2 associated lipids
Hearing Loss, Functional D006315 2 associated lipids
Onychomycosis D014009 2 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Biberfeld G and Sterner G A study of Mycoplasma pneumoniae infections in families. 1969 Scand. J. Infect. Dis. pmid:4938476
Calame W et al. Influence of cytostatic treatment on the efficacy of erythromycin and roxithromycin in a staphylococcal infection in mice. 1990 Scand. J. Infect. Dis. pmid:2149467
Nordström K et al. An outbreak of Legionnaires' disease in Sweden: report of sixty-eight cases. 1983 Scand. J. Infect. Dis. pmid:6844878
Dornbusch K et al. Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. 1974 Scand. J. Infect. Dis. pmid:4496865
Kalin M et al. Frequency and type distribution of pneumococcal strains in the Stockholm region with resistance or reduced susceptibility to antibiotics. 1984 Scand. J. Infect. Dis. pmid:6607514
Gnarpe H Erythromycin, ampicillin, alkalization and increased diuresis in treatment of human L-phase urinary tract infections. 1974 Scand. J. Infect. Dis. pmid:4597598
Holmström L et al. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres. 1990 Scand. J. Infect. Dis. pmid:2113310
Grahn E et al. Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis. 1987 Scand. J. Infect. Dis. pmid:3118452
Vorland LH et al. Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus. 1999 Scand. J. Infect. Dis. pmid:10447328
Cohen J et al. Mediterranean spotted fever in pregnancy. 1999 Scand. J. Infect. Dis. pmid:10447334
Roos K et al. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis--a randomized placebo-controlled multicentre study. 1996 Scand. J. Infect. Dis. pmid:8953674
Kamme C Evaluation of the in vitro sensitivity of Neisseria catarrhalis to antibiotics with respect to acute otitis media. 1970 Scand. J. Infect. Dis. pmid:4999774
Schugk J et al. A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period. 1997 Scand. J. Infect. Dis. pmid:9255881
Baty V et al. Legionella jordanis pneumonia unresponsive to fluoroquinolones in a non-immunocompromised host. 1997 Scand. J. Infect. Dis. pmid:9255901
Uriz S et al. Neisseria meningitidis with reduced sensitivity to penicillin: observations in 10 children. 1991 Scand. J. Infect. Dis. pmid:1906633
Söderström M et al. Erythromycin and phenoxymethylpenicillin (penicillin V) in the treatment of respiratory tract infections as related to microbiological findings and serum C-reactive protein. 1991 Scand. J. Infect. Dis. pmid:1909052
Hammers-Berggren S et al. Erythromycin for treatment of ornithosis. 1991 Scand. J. Infect. Dis. pmid:1853163
Vikerfors T et al. Detection of specific IgM antibodies for the diagnosis of Mycoplasma pneumoniae infections: a clinical evaluation. 1988 Scand. J. Infect. Dis. pmid:3146809
Koliou M et al. Murine typhus in pregnancy: a case report from Cyprus. 2007 Scand. J. Infect. Dis. pmid:17577832
Bengtsson E et al. Azidocillin treatment of enterococcal septicemia. 1972 Scand. J. Infect. Dis. pmid:4341815
Ruess M et al. Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital. 2000 Scand. J. Infect. Dis. pmid:11200371
Ringertz S and Kronvall G Increased use of erythromycin causes resistance in Haemophilus influenzae. 1987 Scand. J. Infect. Dis. pmid:3497435
Nissinen A et al. Detecting erythromycin resistance in Streptococcus pyogenes: reliability of the disk diffusion method and the breakpoint susceptibility testing method. Finnish Study Group for Antimicrobial Resistance (FIRE). 1995 Scand. J. Infect. Dis. pmid:7784814
Norinder A et al. Economic analysis of treatment with roxithromycin in comparison with erythromycin in patients with lower respiratory tract infections. 1997 Scand. J. Infect. Dis. pmid:9112304
Schwartzman WA et al. Epithelioid angiomatosis or cat scratch disease with splenic and hepatic abnormalities in AIDS: case report and review of the literature. 1990 Scand. J. Infect. Dis. pmid:2192439
Kjellman B and Henningsson R Patterns of antimicrobial therapy for pediatric patients. 1984 Scand. J. Infect. Dis. pmid:6695154
Slomiany BL et al. Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents. 1995 Scand. J. Gastroenterol. Suppl. pmid:8578215
Gad A et al. Campylobacter pylori and non-ulcer dyspepsia. 2. A prospective study in a Swedish population. 1989 Scand. J. Gastroenterol. Suppl. pmid:2617168
Szary NM et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. 2011 Scand. J. Gastroenterol. pmid:21561232
Björnsson ES and Abrahamsson H Comparison between physiologic and erythromycin-induced interdigestive motility. 1995 Scand. J. Gastroenterol. pmid:7732336
Petrakis IE et al. Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis. 1999 Scand. J. Gastroenterol. pmid:10365900
Chini P et al. Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility. 2012 Scand. J. Gastroenterol. pmid:22364597
Fiorucci S et al. Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients. 1994 Scand. J. Gastroenterol. pmid:7824860
Bratlid D The effect of antimicrobial agents on bilirubin binding by human erythrocytes. 1972 Scand. J. Clin. Lab. Invest. pmid:4629675
Hoyme UB Chlamydial infections in gynaecology and obstetrics. 1987 Scand J Urol Nephrol Suppl pmid:3481465
Wilczek H et al. Experience with 5 cases of Legionnaires' disease at the Department of Transplantation Surgery, Huddinge Hospital, Stockholm, Sweden. 1985 Scand J Urol Nephrol Suppl pmid:3914064
Hamann K and Thorn P Systemic or local treatment of erythrasma? A comparison between erythromycin tablets and Fucidin cream in general practice. 1991 Scand J Prim Health Care pmid:2041927
Mabeck CE Prescription of antibacterial drugs for treatment of bronchitis and pneumonia in general practice in Denmark. 1983 Scand J Prim Health Care pmid:6443588
Tally FP et al. Clindamycin resistance in anaerobic bacteria. 1984 Scand J Infect Dis Suppl pmid:6598519
Renkonen OV Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis. 1983 Scand J Infect Dis Suppl pmid:6606222
Mattie H A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics. 1990 Scand J Infect Dis Suppl pmid:2129065
Friberg D and Lundberg C Antibiotic prophylaxis in major head and neck surgery when clean-contaminated wounds are established. 1990 Scand J Infect Dis Suppl pmid:2287908
Granström G et al. Whooping cough in late pregnancy. 1990 Scand J Infect Dis Suppl pmid:2287912
Liss RH et al. Comparative study of erythromycin, amoxicillin and ampicillin antimicrobial activity against human respiratory tract pathogens. 1979 Scand J Infect Dis Suppl pmid:44765
Helin I and MÃ¥rdh PA Mother-to-infant transmission of Chlamydia trachomatis and its consequences for the baby. 1982 Scand J Infect Dis Suppl pmid:6958009
Lassus A and Juvakoski T Treatment of uncomplicated genital Chlamydia trachomatis infections in males. 1982 Scand J Infect Dis Suppl pmid:6958014
Gjønnaess H Treatment of Chlamydia trachomatis infections of the female lower genital tract. 1982 Scand J Infect Dis Suppl pmid:6958016
Short-Course Therapy: Improved Patient Compliance and Therapeutic Benefit. Proceedings of a symposium at the 5th European Congress of Clinical Microbiology and Infectious Diseases. Oslo, Norway, 9-11 September 1991. 1992 Scand J Infect Dis Suppl pmid:1362621
Møller BR et al. Occurrence of Ureaplasma urealyticus and Mycoplasma hominis in non-gonococcal urethritis before and after treatment in a double-blind trial of ofloxacin versus erythromycin. 1990 Scand J Infect Dis Suppl pmid:2218419
Rylander M and Hallander HO In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. 1988 Scand J Infect Dis Suppl pmid:2843982